UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000010122
Receipt No. R000011856
Scientific Title Clinical Efficacy of Cefditoren Pivoxil for Exacerbation of Chronic Obstructive Pulmonary Disease
Date of disclosure of the study information 2013/02/27
Last modified on 2019/09/05 10:38:56

No. Disposal Last modified on Item of update
1 Insert 2013/02/26 12:19:57
2 Update 2014/01/06 17:43:18 Email
Last name of contact person
Last name of contact person
Address
Address
TEL
Name of person sending information
Name of person sending information
Email
3 Update 2014/02/27 13:50:12 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
4 Update 2014/02/27 14:13:35 Key exclusion criteria
Target sample size
5 Update 2014/02/27 14:17:41 Institutions
6 Update 2014/03/03 08:52:08 Key exclusion criteria
7 Update 2014/03/27 11:37:56 Institutions
8 Update 2014/08/26 10:44:59 Address
Address
TEL
9 Update 2015/02/26 11:55:59 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
10 Update 2015/02/26 12:04:01 Institutions
11 Update 2015/02/26 12:13:28 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
12 Update 2016/08/30 14:12:22 Division name
Division name
Division name
Division name
Name of primary sponsor
Organization
Institutions
13 Update 2016/08/30 14:39:54 Division name
Division name
Division name
Division name
14 Update 2017/05/23 15:14:06 Recruitment status
15 Update 2017/05/23 18:17:28 Recruitment status
16 Update 2017/08/31 11:58:36 Address
Address
TEL
17 Update 2018/03/02 14:28:12 Email
18 Update 2019/07/09 12:13:49 Recruitment status
Date of IRB
19 Update 2019/09/05 10:38:56 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures


Contact us.